Investment Regulation and Incentives

Many consumers are familiar with the acronym GMP because it has been printed on labels of drugs, food supplements, and cosmetic products. This acronym, which comes from the term Good Manufacturing Practice, is a standard which ensures that food, food supplements, medicines and cosmetics are safe for consumption.
Nowadays, cell therapy is continuously progressing to reach its potential. The therapy aims to improve the quality of life of healthy people, and the treatment of severe rare diseases. However, given the complexity and ongoing development of cell therapy, in 2019 the Canadian government revised the regulations on cell therapy to emphasize the safety of patients, the effectiveness of treatment, and importantly the promotion of industrial development.
From 2018 until the beginning of 2019, the United States Food and Drug Agency (FDA) announced eight recommended guidelines in cell and gene therapy. The guidelines helped the regulatory body keep up with changes in the industry and create a regulatory landscape in the field of cells and gene therapy in response to the rapid development of the industry and the common interests of the industry and patients.
Many consumers are familiar with the acronym GMP because it has been printed on labels of drugs, food supplements, and cosmetic products.
The Thai Food and Drug Administration (FDA) issued a second notification of the Ministry of Public Health regarding test kits related to HIV infection B.E. 2562 and a notification of the Ministry of Public Health regarding HIV self-test kits B.E. 2562
According to the World Health Organization (WHO), Thailand is struggling with tuberculosis (TB) and is one of the 14 countries worst hit by this severely infectious disease.
In March 2019, the Singapore Parenteral Drug Association (PDA) meeting focused on the development of "Advanced Therapy Medicinal Products (ATMPs)." One of the presenters predicted that the growth of ATMPs there would exceed over 900 percent within 2019, and the growth rate would come from the development of cell therapy technology used in conjunction with medical tools.

Although the Thai government has introduced measures to promote investment in 12 new target industries (S-curve), including medical devices and medical robotics industry, Thailand can benefit even more from the trade war between China and the US, conditionally offering additional benefits to attract foreign investment. As a result, the Minister of Industry ordered the Office of Industrial Economics (OIE) to review and suggest additional benefit packages for foreign investment in the target industries, especially investment in the Eastern Special Development Zone (EEC).

Due to the trend of health focused and aging society, the market of medical foods and food supplements is growing at high pace. The medicals foods are specially formulated and intended for the dietary management of a disease or condition that has distinctive nutritional needs that cannot be met by normal diet alone.
Currently, Thai investment promotion policy on the medical devices industry is mainly under the guidance and execution of Board of Investment (BOI). There are two main measures of the BOI those are tax and non-tax measures.
Page view : 2676